Optimizing Tactics for Use of the U.S. Antiviral Strategic National Stockpile for Pandemic Influenza
2011

Optimizing Antiviral Distribution for Pandemic Influenza

publication Evidence: high

Author Information

Author(s): Dimitrov Nedialko B., Goll Sebastian, Hupert Nathaniel, Pourbohloul Babak, Meyers Lauren Ancel

Primary Institution: University of Texas at Austin

Hypothesis

How can the U.S. antiviral stockpile be optimally distributed during a pandemic to minimize infections?

Conclusion

An aggressive community-based antiviral treatment strategy can effectively slow the transmission of mildly transmissible strains like pH1N1.

Supporting Evidence

  • The U.S. government distributed a quarter of the antiviral medications in the Strategic National Stockpile within weeks of the pandemic's start.
  • The study suggests that appropriate antiviral treatment may be an effective mitigation strategy during the early stages of future influenza pandemics.
  • Optimized strategies depend on the transmissibility of the virus and rates of antiviral uptake and wastage.

Takeaway

This study shows how to best share antiviral medicines during a flu outbreak to help sick people and stop the spread of the virus.

Methodology

The study used a tactical optimization model to analyze the distribution of antiviral medications based on a stochastic network model of influenza transmission.

Limitations

The study did not consider the development of antiviral resistance or the use of antivirals for prophylaxis.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016094

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication